159 related articles for article (PubMed ID: 37943128)
1. [Hope for a new treatment for castration-resistant prostate cancer].
Terzic J; Metzger D
Med Sci (Paris); 2023 Oct; 39(10):709-711. PubMed ID: 37943128
[No Abstract] [Full Text] [Related]
2. Advances in systemic therapies for metastatic castration-resistant prostate cancer.
Pant MK; Abughaban A; Aragon-Ching JB
Future Oncol; 2014 Nov; 10(14):2213-26. PubMed ID: 25471035
[TBL] [Abstract][Full Text] [Related]
3. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.
Crawford ED; Higano CS; Shore ND; Hussain M; Petrylak DP
J Urol; 2015 Dec; 194(6):1537-47. PubMed ID: 26196735
[TBL] [Abstract][Full Text] [Related]
4. Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment.
Mansinho A; Macedo D; Fernandes I; Costa L
Adv Exp Med Biol; 2018; 1096():117-133. PubMed ID: 30324351
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment for castration-resistant prostate cancer.
Izumi K; Namiki M
Asian J Androl; 2014; 16(3):498. PubMed ID: 24759581
[No Abstract] [Full Text] [Related]
6. Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?
Heidegger I; Brandt MP; Heck MM
Urol Oncol; 2020 Apr; 38(4):129-136. PubMed ID: 31953000
[TBL] [Abstract][Full Text] [Related]
7. [Current status and future direction of the treatment of CRPC (castration resistant prostate cancer)].
Akaza H
Nihon Rinsho; 2014 Dec; 72(12):2108-15. PubMed ID: 25518342
[TBL] [Abstract][Full Text] [Related]
8. Sequential therapies in castration-resistant prostate cancer.
Buonerba C; Di Lorenzo G
Future Oncol; 2014 Feb; 10(2):153-5. PubMed ID: 24490599
[No Abstract] [Full Text] [Related]
9. [Current status and prospects of immunotherapy for castration-resistant prostate cancer].
Yatsuda J; Eto M
Nihon Rinsho; 2014 Dec; 72(12):2174-8. PubMed ID: 25518354
[TBL] [Abstract][Full Text] [Related]
10. [Management of patients with castration-resistant metastatic prostate cancer].
Ondruš D; Ondrušová M
Klin Onkol; 2015; 28(1):24-9. PubMed ID: 25692752
[TBL] [Abstract][Full Text] [Related]
11. [Metastatic castration resistant prostate cancer: 2018 perspective.].
Miñana López B
Arch Esp Urol; 2018 Sep; 71(8):625-627. PubMed ID: 30319122
[No Abstract] [Full Text] [Related]
12. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
13. Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer.
Climent MÁ; León-Mateos L; González Del Alba A; Pérez-Valderrama B; Méndez-Vidal MJ; Mellado B; Arranz JÁ; Sánchez-Hernández A; Cassinello J; Olmos D; Carles J
Crit Rev Oncol Hematol; 2015 Nov; 96(2):308-18. PubMed ID: 26100652
[TBL] [Abstract][Full Text] [Related]
14. New developments in the treatment of castration resistant prostate cancer.
Wadia R; Petrylak DP
Asian J Androl; 2014; 16(4):555-60. PubMed ID: 24759588
[TBL] [Abstract][Full Text] [Related]
15. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
[TBL] [Abstract][Full Text] [Related]
16. [Updated treatments of castration-resistant prostate cancer].
Wei YF; Gu XJ; Zhu QY
Zhonghua Nan Ke Xue; 2016 May; 22(5):455-61. PubMed ID: 27416673
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.
Tucci M; Caffo O; Buttigliero C; Cavaliere C; D'aniello C; Di Maio M; Kinspergher S; Maines F; Rizzo M; Rossetti S; Veccia A; Scagliotti GV; Facchini G
Cancer Treat Rev; 2019 Mar; 74():35-42. PubMed ID: 30738364
[TBL] [Abstract][Full Text] [Related]
18. Castration-Resistant Prostate Cancer: Sequencing Oral and Infusion Agents.
Starosta SB; Savage SJ
Curr Urol Rep; 2018 Jul; 19(9):73. PubMed ID: 30030649
[TBL] [Abstract][Full Text] [Related]
19. Should the Urologist Treat Castration Resistant Prostate Cancer? No.
Petrylak DP
J Urol; 2015 Aug; 194(2):286-7. PubMed ID: 25986508
[No Abstract] [Full Text] [Related]
20. [Castration resistant prostate cancer 2015].
Merseburger AS; Böker A; Kuczyk MA; von Klot CA
Aktuelle Urol; 2015 Jan; 46(1):59-65. PubMed ID: 25658232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
